Form EFFECT EUPRAXIA PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 24, 2026 9:00 A.M. |
| Form: | F-10 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Leaders Unite In Kenya For Historic Convening To Help End FGM/C And Child Marriage
- Diamond Properties’ Mark Blanford and Jeff Haack Receive CoStar’s Q2 2026 Power Broker Quarterly Deals Award
- AirTripMaker Expands US–India Travel Network, Strengthening Connections Between the United States and Major Indian Cities
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
